← All trials
NCT04723537
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 16, 2021
- Primary completion
- Sep 30, 2022
- Completion date
- Sep 30, 2022
- First posted
- Jan 25, 2021
- Last posted
- Nov 16, 2021
- Enrollment
- 310
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- RedHill BiopharmaLead sponsor
- RedHill BiopharmaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.